Inhibition of stress-activated protein kinase in the ischemic/reperfused heart: Role of magnesium tanshinoate B in preventing apoptosis

Biochemical Pharmacology

Volumn 62, Issue 4, 2001, Pages 483-493

  Au Yeung, Kathy K W ^a   Zhu, Da yuan ^b   Karmin O, ^a   Siow, Yaw L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Apoptosis; Ischemia; Protein kinases; Protein phosphorylation; Reperfusion

Indexed keywords

MAGNESIUM TANSHINOATE B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN C JUN; SALVIA MILTIORRHIZA EXTRACT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035882751     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00686-4     Document Type: Article

References (50)

1. Signal transduction by the c-Jun N-terminal kinase (JNK) - From inflammation to development
2. Stress-activated protein kinases in cardiovascular disease
3. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney
4. A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion
5. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion
6. Myocardial damage during ischaemia and reperfusion
7. Regulation of fos and jun immediate-early genes by redox or metabolic stress in cardiac myocytes
8. Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1β-converting enzyme inhibition
9. Activation of the JNK pathway is important for cardiomyocyte death in response to simulated ischemia
10. Apoptosis: Basic mechanisms and implications for cardiovascular disease
11. Apoptosis in myocardial ischemia-reperfusion
12. Apoptosis in the heart: When and why?
13. Apoptosis in the failing human heart
14. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol
15. Herbs that regulate the blood
16. Herbs promoting blood circulation and dissolving blood stasis
17. Cardiovascular pharmacology of Panax notoginseng (Burk) F.H. Chen and Salvia miltiorrhiza
18. Studies on cardiovascular actions of Salvia miltiorrhiza
19. Hypotensive effects of lithospermic acid B isolated from the extract of Salviae miltiorrhizae Radix in the rat
20. Protective effect of Danshen during myocardial ischemia and reperfusion: An isolated rat heart study
21. Therapeutic effect of sodium tanshinone IIA sulfonate in patients with coronary heart disease. A double blind study
22. Endothelium-dependent vasodilator effects of the extract from Salviae miltiorrhizae radix: A study on the identification of lithospermic acid B in the extracts
23. Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza
24. Effect of Flos carthami on stress-activated protein kinase activity in the isolated reperfused rat heart
25. Identification of dying cells - In situ staining
26. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
27. Cleavage of poly(ADP-ribose) polymerase: A sensitive parameter to study cell death
28. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions
29. A mammalian scaffold complex that selectively mediates MAP kinase activation
30. Early apoptosis in human myocardial infarcts
31. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options
32. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes
33. Magnesium tanshinoate B (MTB) inhibits low density lipoprotein oxidation
34. Lithospermic acid B as an antioxidant-based protector of cultured ventricular myocytes and aortic endothelial cells of rabbits
35. Confirmation that magnesium lithospermate B has a hydroxyl radical-scavenging action
36. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits
37. Activation of p38 and c-jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C
38. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
39. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42
40. Proto-oncogene expression in porcine myocardium subjected to ischemia and reperfusion
41. Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase
42. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxic cardiac myocytes
43. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis
44. Programmed cell death in the absence of c-Fos and c-Jun
45. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
46. Molecular and cellular biology of heart failure
47. Co-localization of the cysteine protease caspase-3 with apoptotic myocytes after in vivo myocardial ischemia and reperfusion in the rat
48. Ischemic preconditioning decreases apoptosis in rat hearts in vivo
49. Mitochondrial membrane permeabilization during the apoptotic process